Strong growth prospects
for strong growth

Intervening in France, Europe and internationally

The problems of isolation, access to care and under-equipped health facilities, while essential in France, are vital for many countries in the world, particularly in Africa and Latin America.

To respond to the structural deficiencies of healthcare models, telemedicine has experienced a meteoric rise and digital health has become the most attractive business sector. Loxamed is one of the players who are at the origin of this movement in France and it wishes to reinforce these transformations by further developing its mission of proximity health́. It has alreadỳ built with all its partners medical, mobile, modular, connected, operational and secure solutions to facilitate access to care, to fluidify medical processes, to act in a preventive way by training, screening, diagnosing and vaccinating.

Loxamed is structured to develop in both the public and private sectors and wishes to expand further in Europe and worldwide.

Frost & Sullivan estimates that the global digital health market will be worth $234.5 billion by 2023, an increase of 160% compared to 2019. This growth is mainly due to the needs of an ageing population and the sharp increase in chronic diseases.

The rise of telemedicine in France
and in the world

In France, teleconsultations have exploded since the first pandemic lockdown (x16 in 6 months), notably thanks to improved legal constraints on reimbursement. At the global level, the teleconsultation market has more than doubled in 5 years, since it is estimated at $41.2 billion in 2021 compared to $20.2 billion in 20161. It is estimated to be worth around €5 billion in France over a five-year period2.

Before the Covid-19 pandemic and since 2018, some teleconsultations were reimbursed when they met certain specific criteria: the practitioner must alreadỳ know the patient; the care pathway must be respected. Telemedicine encompasses different acts, for which Loxamed offers many solutions: teleconsultation, tele-expertise, remote monitoring, remote assistance, medical response brought in the framework of medical regulation. During the Covid-19 pandemic, telemedicine demonstrated́ that it was a major asset to protect the health of the greatest number of people.

1. Source: Statista
2. Sources: Institut Montaigne / McKinsey & Company
3. Source: "Le Nouvel Économiste

Containment has made it possible to change the regulations so that
that all teleconsultations are reimbursed by the health insurance, especially if the practitioner does not know the patient.
In the last week of April 2020 and due to the pandemic measures, the French health insurance recorded 1 million teleconsultations compared to 10,000 in early March. 4.5 million teleconsultations took place in the whole month of April alone, compared to 75,000 in 2019. The number of teleconsultations rises to 1.9 million in November 2020.
In the medium term, 15-25% of physical consultations could switch to teleconsultation. This could reduce the number of daily trips by half a million (out of a total of 43 million) in the Île-de-France region3.


Number of patients using teleconsultation

(in October 2020 compared to the pre-pandemic period)


Number of practitioners using teleconsultation

(in October 2020 compared to the pre-pandemic period)


Global telemedicine market in 2021


is developing in West Africa


Loxamed was one of the companies invited by the MEDEF on 26 and 27 October 2021. It was an opportunity for the Loxamed team, led by its Managing Director, Matthieu Guillotin, and accompanied by Cédric Lacour, Commercial Director, and Doctor François Teboul from Télédok, to meet the Rwandan authorities.

With Franck Riester, Minister Delegate to the Minister for Europe and Foreign Affairs, in charge of Foreign Trade and Attractiveness.

With the Rwandan Minister of Health Daniel Ngamije.

The mobile medical solutions offered by Loxamed will be installed initially in the capital Kigali before being deployed throughout the country.